| RS1558111861 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1558112968 |
FLVCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1558115754 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1558115970 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1558118957 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS1558119445 |
GJC2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1558121050 |
FLVCR1
|
Health Risk |
Pathogenic |
Posterior column ataxia-retinitis pigmentosa syndrome, Posterior column ataxia-retinitis pigmentosa syndrome |
| RS1558121260 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1558123212 |
IBA57
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 74, Multiple mitochondrial dysfunctions syndrome 3 |
| RS1558123786 |
COA6
|
Health Risk |
Pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS1558127317 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1558132353 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1558132909 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, LMNA-related disorder |
| RS1558133157 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1558133435 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1558133731 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1558135172 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1558138741 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 12 |
| RS1558141330 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1558146243 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1558146278 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1558146453 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS1558146829 |
ASH1L
|
Health Risk |
Conflicting classifications of pathogenicity |
ASH1L-related disorder, ASH1L-related disorder |
| RS1558146839 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1558148010 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1558148080 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1558148865 |
ZBTB18
|
Health Risk |
Likely pathogenic |
— |
| RS1558149683 |
ASH1L
|
Health Risk |
Likely pathogenic |
— |
| RS1558149913 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1558150761 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Amelogenesis imperfecta type 1A, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1558150870 |
ASH1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1558151466 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome |
| RS1558151555 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Ear malformation |
| RS1558151783 |
ASH1L
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1558151861 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1558153783 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1558153994 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1558154010 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1558154149 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, MPZ-related disorder |
| RS1558154193 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS1558154644 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1558154754 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1558155838 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1558162157 |
CFH
|
Health Risk |
Pathogenic |
Hemolytic uremic syndrome, atypical |
| RS1558163550 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS1558164428 |
RORC
|
Health Risk |
Likely pathogenic |
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency |
| RS1558164647 |
SDHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1558168052 |
SLC35D1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1558182956 |
SDHC
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1558184644 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS1558186011 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
HNRNPU-related disorder, Developmental and epileptic encephalopathy |
| RS1558188078 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1558190256 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS1558190339 |
TBX19
|
Health Risk |
Pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS1558190846 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Intellectual disability |
| RS1558190933 |
HNRNPU
|
Health Risk |
Likely pathogenic |
— |
| RS1558191518 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS1558192351 |
TBX19
|
Health Risk |
Pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS1558192723 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1558193255 |
TBX19
|
Health Risk |
Likely pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS1558193923 |
PKP1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex due to plakophilin deficiency, Epidermolysis bullosa simplex due to plakophilin deficiency |
| RS1558209947 |
DEGS1
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS1558209997 |
DEGS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS1558210191 |
DEGS1
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS1558211070 |
DEGS1
|
Health Risk |
Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS1558212305 |
COQ8A
|
Health Risk |
Likely pathogenic |
Coenzyme Q10 deficiency, primary |
| RS1558225569 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS1558225837 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS1558229491 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1558243381 |
TNNT2
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1D, Dilated cardiomyopathy 1D |
| RS1558244152 |
USH2A;USH2A-AS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1558245626 |
REN
|
Health Risk |
Likely pathogenic |
— |
| RS1558249837 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1558251708 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1558251710 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1558251712 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1558251742 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1558258551 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1558264109 |
TGFB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 4, Familial thoracic aortic aneurysm and aortic dissection |
| RS1558264130 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1558264626 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS1558269982 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1558275354 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1558275372 |
NBAS
|
Health Risk |
Likely pathogenic |
NBAS-related disorder, NBAS-related disorder |
| RS1558276054 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1558276082 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1558276157 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1558280170 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Hyperparathyroidism 1 |
| RS1558282769 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1558283535 |
CDC73
|
Health Risk |
Likely pathogenic |
— |
| RS1558283792 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1558283853 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1558284033 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 1 |
| RS1558284062 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1558304580 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS1558307375 |
TPO
|
Health Risk |
Pathogenic |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS1558307853 |
YY1AP1
|
Health Risk |
Pathogenic |
Grange syndrome, Grange syndrome |
| RS1558308998 |
CACNA1E
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS1558310707 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1558315590 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |